Patent ID: 11964047
Assignee: ETERNATEAR, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 16:
17. A method for lubricating an eye comprising the step of:
administering an ophthalmic suspension to an eye of a patient in need of treatment, the ophthalmic suspension comprising:
i) an aqueous phase comprising water and one or more components selected from the group consisting of at least one wax ester, at least one anionic polar surfactant, at least one nonionic surfactant, at least one salt, and at least one phosphate; and
ii) an oil phase comprising at least one mineral oil and, optionally, at least one wax ester,

wherein, upon administration, the ophthalmic suspension recreates or rebuilds one or more layers of the eye's tear film and maintains integrity of the tear film for over 60 minutes, and
wherein the ophthalmic suspension exhibits a Zeta potential of from about −60 mV to about −110 mV.